COST

1,028.39

-2.11%↓

81.61

+0.52%↑

144.46

+0.77%↑

189.2

+0.55%↑

PEP

150.54

+1.09%↑

COST

1,028.39

-2.11%↓

81.61

+0.52%↑

144.46

+0.77%↑

189.2

+0.55%↑

PEP

150.54

+1.09%↑

COST

1,028.39

-2.11%↓

81.61

+0.52%↑

144.46

+0.77%↑

189.2

+0.55%↑

PEP

150.54

+1.09%↑

COST

1,028.39

-2.11%↓

81.61

+0.52%↑

144.46

+0.77%↑

189.2

+0.55%↑

PEP

150.54

+1.09%↑

COST

1,028.39

-2.11%↓

81.61

+0.52%↑

144.46

+0.77%↑

189.2

+0.55%↑

PEP

150.54

+1.09%↑

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

4.94 -0.6

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.89

Max

4.96

Schlüsselkennzahlen
By Trading Economics
Einkommen	-8.9M -15M
Verkäufe	-7.9M 23M
Gewinnspanne	-64.588
Angestellte	382

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+35.29% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-102M 139M
Vorheriger Eröffnungskurs	5.54
Vorheriger Schlusskurs	4.94

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

25. Mai 2026, 08:24 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Uber's $11.6 Billion Takeover Approach Lifts Delivery Hero Shares

25. Mai 2026, 21:22 UTC

Ergebnisse

Disney's 'Mandalorian and Grogu' Conquers Memorial Day Weekend Box Office -- Barrons.com

25. Mai 2026, 20:50 UTC

Market Talk

Ergebnisse

Basic Materials Roundup: Market Talk

25. Mai 2026, 16:20 UTC

Market Talk

Ergebnisse

Basic Materials Roundup: Market Talk

25. Mai 2026, 16:01 UTC

Market Talk

China's Crude Imports Pullback Helps Cap Price Upside -- Market Talk

25. Mai 2026, 14:43 UTC

Market Talk

Oil Unlikely to Fall Significantly Until Hormuz Fully Reopens -- Market Talk

25. Mai 2026, 14:15 UTC

Market Talk

Crude Futures Retreat As U.S.-Iran Progress Toward Deal -- Market Talk

25. Mai 2026, 13:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

25. Mai 2026, 12:58 UTC

Market Talk

Over 60% of Albertans Indicate No Interest in Separation From Canada -- Market Talk

25. Mai 2026, 12:56 UTC

Market Talk

Ergebnisse

Canadian Earnings Lifted by Higher Commodity Prices in Latest Quarter -- Market Talk

25. Mai 2026, 12:48 UTC

Market Talk

Interest-Rate Cuts Unlikely in 2026 Even if Middle East Conflict Ends -- Market Talk

25. Mai 2026, 12:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

25. Mai 2026, 12:34 UTC

Market Talk

Dollar Extends Falls on U.S.-Iran Deal Prospects -- Market Talk

25. Mai 2026, 12:10 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Delivery Hero's Assets Look Strategic -- Market Talk

25. Mai 2026, 11:00 UTC

Market Talk

Euro, Sterling, Riskier Currencies Rise Versus Weaker Dollar -- Market Talk

25. Mai 2026, 10:19 UTC

Market Talk

Swiss Franc Rises to Highest in More Than Two Months Vs Euro -- Market Talk

25. Mai 2026, 10:05 UTC

Ergebnisse

Tenaga Nasional: Well-Positioned to Navigate Global Geopolitical Uncertainties

25. Mai 2026, 10:04 UTC

Ergebnisse

Tenaga Nasional: Operational Performance to Remain Resilient in 2026

25. Mai 2026, 10:03 UTC

Ergebnisse

Tenaga Nasional: 1Q Operating Profit Rose on Higher Electricity Demand, Lower Fuel Prices

25. Mai 2026, 10:02 UTC

Ergebnisse

Tenaga Nasional: 1Q Rev Rose on Higher Electricity Sales

25. Mai 2026, 10:01 UTC

Ergebnisse

Tenaga Nasional 1Q Net Up 3.7% on Year

25. Mai 2026, 10:00 UTC

Ergebnisse

Tenaga Nasional 1Q Rev Up 6.6% on Year

25. Mai 2026, 09:56 UTC

Ergebnisse

Tenaga Nasional Malaysia 1st-Quarter 2026 Earnings Summary Table

25. Mai 2026, 09:56 UTC

Ergebnisse

Tenaga Nasional 1Q EPS MYR0.1883

25. Mai 2026, 09:56 UTC

Ergebnisse

Tenaga Nasional 1Q Rev MYR17.1B

25. Mai 2026, 09:56 UTC

Ergebnisse

Tenaga Nasional 1Q Net MYR1.1B

25. Mai 2026, 09:38 UTC

Market Talk

U.S.-Iran Talks Lifted Sentiment But No Agreement Would Quickly Restore Normal Market Conditions -- Market Talk

25. Mai 2026, 09:33 UTC

Market Talk

Global Equities Roundup: Market Talk

25. Mai 2026, 09:33 UTC

Market Talk

India's Gold Import Tax Raise Won't Curb Demand -- Market Talk

25. Mai 2026, 08:55 UTC

Market Talk

European Energy Stocks Slide on Falling Oil Prices -- Market Talk

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Kursziel

By TipRanks

35.29% Vorteil

12-Monats-Prognose

Durchschnitt 6.67 USD 35.29%

Hoch 9 USD

Tief 5 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lifecore Biomedical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.